ORASURE TECHNOLOGIES, INC Total Contract Liability
ORASURE TECHNOLOGIES, INC (OSUR) had Total Contract Liability of $1.11 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-08-07
- 2026-06-30: Contract with Customer, Liability $1.11M.
- 2026-03-31: Contract with Customer, Liability $961.00K.
- 2025-12-31: Contract with Customer, Liability $148.00K.
- 2025-06-30: Contract with Customer, Liability $1.46M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2026-06-30 | $1.11M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $961.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $148.00K 10-Q · filed 2026-08-07 | |
| 2025-06-30 | $1.46M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $771.00K 10-Q · filed 2026-05-08 | $974.00K 10-Q · filed 2025-08-06 |
| 2024-12-31 | $974.00K 10-Q · filed 2026-08-07 | $2.96M 10-K · filed 2025-03-07 |
| 2024-03-31 | $774.00K 10-Q · filed 2025-08-06 | |
| 2023-12-31 | $1.19M 10-Q · filed 2025-08-06 | $1.56M 10-K · filed 2024-03-11 |
| 2022-12-31 | $2.27M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |